Endotoxin: Clinical Trials

6 trials of Endotoxin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 enrolling by invitation, 1 not yet recruiting. 6 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 26Completed 4, Enrolling by invitation 1, Not yet recruiting 1
Phase 11Completed 1
Phase 31Completed 1

Follow Endotoxin: new trials by email Literature Review of Endotoxin trials Research Report on Endotoxin

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Endotoxin Exposure to Examine the Role of Inflammation in Alcohol Use
Endotoxin, Placebo saline - Alcohol Use Disorder, Inflammatory Response
Phase 2Not yet recruitingUniversity of California, Los Angeles642026-09-012026-08-28
Effect of Endotoxin on Alcohol Consumption
Endotoxin - Alcohol Use Disorder
Phase 2CompletedYale University272022-02-272025-11-03
An Inflammatory Challenge Using Endotoxin
Placebo, Endotoxin - Alcohol Use Disorder, Inflammatory Response
Phase 2CompletedUniversity of California, Los Angeles202021-10-192025-05-01
The Innate Central Nervous System Immune Response to an Experimental Immune Challenge in People With Fibromyalgia
Endotoxin, Escherichia Coli, Magnetic Resonance Spectroscopy - Fibromyalgia
Phase 2 / Phase 3CompletedUniversity of Alabama at Birmingham362020-03-112023-04-14
Effects of Bronchial Segmental Endotoxin Instillation in Humans
Saline, Endotoxin - Acute Lung Inflammation
Phase 2Enrolling by invitationNational Institutes of Health Clinical Center (CC)582015-06-182026-10-16
Wilm's Tumor 1 Protein Vaccine to Treat Cancers of the Blood
WT1 Peptide-Pulsed Dendritic Cells, Donor Lymphocytes, IL-4 - Leukemia, Acute Myelogenous (AML), Leukemia, Acute Lymphocytic (ALL)
Phase 1 / Phase 2CompletedNational Cancer Institute (NCI)102008-02-222017-04-12

Conditions studied

Alcoholism (3)  ·  Chronic Pain (1)  ·  Consciousness Disorders (1)  ·  Fibromyalgia (1)  ·  Hematologic Neoplasms (1)  ·  Hodgkin Disease (1)  ·  Leukemia (1)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Myelodysplastic Syndromes (1)  ·  Neuroinflammatory Diseases (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)

Sponsors

University of California, Los Angeles (2)  ·  National Cancer Institute (NCI) (1)  ·  National Institutes of Health Clinical Center (CC) (1)  ·  University of Alabama at Birmingham (1)  ·  Yale University (1)

Countries

United States (5)

Top investigators

Lara Ray, PhD (2)  ·  Anthony F Suffredini, M.D. (1)  ·  Jarred M Younger, PhD (1)  ·  Terril Verplaetse, PhD (1)  ·  Terry J Fry, M.D. (1)

NIH funding

K24AA025704 (1), R03AA028361 (1)